Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hsieh

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Epilepsia|October 25, 2022
Beyond seizure freedom: Dissecting long-term seizure control after surgical resection for drug-resistant epilepsyJason K Hsieh, Francesco G Pucci, Swetha J Sundar, et al.
Nature Communications|September 16, 2024
Cortical sites critical to language function act as connectors between language subnetworksJason K Hsieh, Prashanth R Prakash, Robert D Flint, et al.
Japanese Journal of Clinical Oncology|March 10, 1998
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experienceW S Wang, P M Chen, T J Chiou, et al.
British Journal of Cancer|July 1, 2004
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerY Chao, K H Yeh, C J Chang, et al.
Japanese Journal of Clinical Oncology|February 24, 2001
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiencyM H Yang, C C Yen, Y H Chang, et al.
Japanese Journal of Clinical Oncology|January 13, 2001
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experienceJ K Lin, W S Wang, R K Hsieh, et al.
Blood Cancer Journal|March 21, 2015
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysisK-H Lim, Y-C Chang, C Gon-Shen Chen, et al.
Oncology|July 1, 1997
Weekly CAF chemotherapy for advanced breast cancer patientsW S Hwang, C A Hsiung, W S Ko, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|June 17, 2026
Integrating Entrustable Professional Activities in Simulation-Based Health Care Education: A Systematic Literature ReviewIsabele Pardo, Julia M G Ferreira, Maria C Gutfreund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Epilepsia|October 25, 2022
Beyond seizure freedom: Dissecting long-term seizure control after surgical resection for drug-resistant epilepsyJason K Hsieh, Francesco G Pucci, Swetha J Sundar, et al.
Nature Communications|September 16, 2024
Cortical sites critical to language function act as connectors between language subnetworksJason K Hsieh, Prashanth R Prakash, Robert D Flint, et al.
Japanese Journal of Clinical Oncology|March 10, 1998
Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experienceW S Wang, P M Chen, T J Chiou, et al.
British Journal of Cancer|July 1, 2004
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancerY Chao, K H Yeh, C J Chang, et al.
Japanese Journal of Clinical Oncology|February 24, 2001
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiencyM H Yang, C C Yen, Y H Chang, et al.
Japanese Journal of Clinical Oncology|January 13, 2001
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experienceJ K Lin, W S Wang, R K Hsieh, et al.
Blood Cancer Journal|March 21, 2015
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysisK-H Lim, Y-C Chang, C Gon-Shen Chen, et al.
Oncology|July 1, 1997
Weekly CAF chemotherapy for advanced breast cancer patientsW S Hwang, C A Hsiung, W S Ko, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|June 17, 2026
Integrating Entrustable Professional Activities in Simulation-Based Health Care Education: A Systematic Literature ReviewIsabele Pardo, Julia M G Ferreira, Maria C Gutfreund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancerJ S Chen, C Hsu, N J Chiang, et al.
Pageof 19